Let there be light: gene and cell therapy for blindness.

Abstract : Retinal degenerative diseases are a leading cause of irreversible blindness. Retinal cell death is the main cause of vision loss in genetic disorders such as retinitis pigmentosa, Stargardt disease and Leber congenital amaurosis, as well as in complex age-related diseases such as age-related macular degeneration (AMD). For these blinding conditions, gene and cell therapy approaches offer therapeutic intervention at various disease stages. The present review outlines recent advances in therapies for retinal degenerative disease, focusing on the progress and challenges in the development and clinical translation of gene and cell therapies. A significant body of preclinical evidence and initial clinical results pave the way for further development of these cutting edge treatments for patients with retinal degenerative disorders.
Type de document :
Article dans une revue
Human Gene Therapy, Mary Ann Liebert, 2016, 27 (2), pp.134-47
Liste complète des métadonnées

Littérature citée [107 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01258538
Contributeur : Katia Marazova <>
Soumis le : mardi 19 janvier 2016 - 11:20:55
Dernière modification le : vendredi 31 août 2018 - 09:13:20
Document(s) archivé(s) le : vendredi 11 novembre 2016 - 11:25:14

Fichier

SAHEL_HGT_MS_accepted for publ...
Fichiers produits par l'(les) auteur(s)

Identifiants

  • HAL Id : inserm-01258538, version 1
  • PUBMED : 26751519

Collections

Citation

Deniz Dalkara, Olivier Goureau, Katia Marazova, Jose-Alain Sahel. Let there be light: gene and cell therapy for blindness.. Human Gene Therapy, Mary Ann Liebert, 2016, 27 (2), pp.134-47. 〈inserm-01258538〉

Partager

Métriques

Consultations de la notice

110

Téléchargements de fichiers

120